UCL Faculty of Medical Sciences is widely recognised as a world leader in
biomedical science and therapeutic innovation. Our biomedical research
capabilities and infrastructure span all stages of the translational spectrum
from basic discovery science to proof-of-mechanism and clinical evaluation in
patients. As Vice-Dean for Enterprise, Professor Rachel Chambers’ role is to
promote Enterprise thinking, Entrepreneurship and Industry Engagement in order
to deliver on our major potential in this highly competitive and fast-moving
- Knowledge Transfer and Enterprise Champions
Our Knowledge Transfer and Enterprise Champions are appointed to promote Knowledge Transfer within UCL and make it easier for academics to receive recognition for their work. The seven KT&E champions working within our four faculties also aim to create inter-departmental links throughout the university, working with champions outside the School of Life and Medical Sciences.
- Read more about our KT champions on the UCL Enterprise pages.
- Translational Research Office
The aims of the TRO are to enhance the translational culture within UCL and to facilitate the translation of UCL’s basic and clinical research into therapies, techniques and medical products with therapeutic value. These aims are achieved through interacting with investigators, identifying translatable opportunities, advising on project progression strategy and accessing suitable funding. The TRO also provides project management expertise to steer programmes towards practical endpoints.
We are able to link investigators to the necessary resources (either internal or external) for projects at all phases - discovery, preclinical or clinical.
Building on a history of increasing collaboration between UCLPartners, King’s Health Partners, Imperial College Academic Health Science Centre, Oxford and Cambridge, MedCity has been established in partnership with the Greater London Authority (GLA) to provide a vehicle to realise that ambition, ensuring London and the Greater South East become the a global hub for the development of novel therapeutics, devices and diagnostics to address medical need.
UCL has remarkable capability across 5 therapeutic innovation networks, reflecting major therapeutic modalities and diagnostic innovation (imaging, genomics, and molecular pathology).[image reference is broken]
For details of UCL's engagement with MedCity visit the UCL@MedCity website.
- Support for Hospital Staff with UCL honorary contracts
Follow the links for where to find help and support if your primary employer is:
If you are employed by another Trust please speak to the UCLB Business Manager for the UCL academic department you are affiliated with in the first instance. They will be able to connect you to the correct support organisation.
- Information about SLMS Impact PhD Studentships
IMPACT studentships support collaborative partnerships between a UCL investigator and external organizations. They allow new partnerships to be established with industrial or enterprise partners, new opportunities for knowledge transfer with external organizations, or support and extend existing partnerships. In recognition of the value of such external partnerships in enterprise and knowledge transfer, UCL makes a significant contribution to the cost of the studentship so that the external partner needs to provide only part of the total funds required.
Please discuss potential applications with your Institute or Division Manager or Director early in the process and certainly prior to any commitment to an external partner. Studentships are part of the annual planning cycle and involve a financial commitment from your Institute or Division. The Vice-Deans, Enterprise, will evaluate the academic merits of individual cases, but only your institute can provide the financial authority for a studentship to progress.
Applications are accepted for IMPACT PhD studentships in each Faculty on a rolling basis. To be considered for an IMPACT studentship, a UCL investigator must identify an external partner and project that fulfills the criteria set out below. The external partner must be willing to commit appropriate supervisory or project support plus a financial commitment as outlined at http://www.ucl.ac.uk/slms/enterprise/funding towards the cost of a three-year PhD. If approved, UCL will then provide the additional funding required. Awards may be used to support 4 year PhDs, where the additional year is charged in full to another source.
IMPACT awards cover home/EU fees, stipend (minimum UK Research Council with London weighting), and research costs of £1000/annum. Any additional costs must be charged entirely to the organisational partner. Awards may be used to support UK and EU nationals only.